Q21— 510(k) K221959

Substantially Equivalent

Neurofield, Inc.

FDA 510(k) clearance K221959 for Q21, Substantially Equivalent on 2023-08-31. Applicant: Neurofield, Inc..

Clearance details

Applicant: Neurofield, Inc.
Product code: Code GWQ
Advisory panel: Neurology
Date received: 2022-07-05
Decision date: 2023-08-31
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bishop, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.